Search results for

In January 2006 the ECJ handed down its judgment rejecting the opposition of the Picasso Estate (owners of the trade mark Picasso) to the registration of the mark Picaro for "vehicles and vehicle parts and omnibuses" in class 12.

Will the introduction of post-grant opposition provide greater opportunities to patent challengers in the US? A letter from John P Sutton

According to a general principle of French law, in any judicial proceedings, the plaintiff has the burden of proving the facts alleged in support of his claims. Therefore, the person purporting to hold an IP right must adduce evidence of the alleged infringement. This evidence must cover five aspects:

A series of recent decisions in Canada and the UK has established rules for the way courts interpret patent claims. Robert H C MacFarlane and Adam Bobker of Bereskin & Parr explain what the changes mean for rights owners

An effective and efficient patent application process is the first step in building a valuable portfolio. Eugene J Gierczak and Daryl W Schnurr of Miller Thomson explain Canada's patent framework

James Nurton, London

One of the most high profile initiatives within the United Arab Emirates (UAE) is the government's support of the media and broadcasting industries. For example, Dubai Media City (DMC) is generally considered an enormous success. In the four years since its creation, DMC has firmly established itself as the media hub of the region. With approximately one thousand companies from over 45 countries, it is described on the government's website as "a vibrant mix of talent and resources". And they're probably right.

In October 2005, the Provincial Appellate Court of Madrid gave an interesting judgment in an action that Lilly Group had brought against two companies in the business of selling generic products. The judgment confirmed that these companies' advertising was illegal and that there was trade mark infringement. The judgment is particularly noteworthy as high damages were awarded compared to what is usual in Spain.

IP concerns are increasingly likely to make or break cross-border M&A deals in China. In the second of a two-part series, Catherine Sun provides a step-by-step guide to getting it right

If you are a big pharmaceutical company, spending millions of dollars to manage your intellectual property every year, you will want to find the best lawyers to advise you on prosecution and litigation matters. But as Susanne Sivborg, vice-president of global intellectual property at AstraZeneca, tells Stéphanie Bodoni, the most experienced lawyers are no good if they do not respond to her company's needs